Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate

Prescription

Noms de marque : Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate

Forme Pharmaceutique

Tablet

Voie d'Administration

ORAL

Fabricant

Rising Pharma Holdings, Inc.

About This Medication

DESCRIPTION Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg monobasic potassium phosphate, and 130 mg monobasic sodium phosphate monohydrate. Each tablet yields approximately 250 mg of phosphorus, 298 mg of sodium (13.0 mEq) and 45 mg of potassium (1 .1 mEq).

Principes Actifs

Ingrédient	Dosage
Potassium Phosphate, Monobasic	-
Sodium Phosphate, Dibasic, Anhydrous	-
Sodium Phosphate, Monobasic, Monohydrate	-

Indications et Utilisation

INDICATIONS AND USAGE PHOSPHA 250 TM NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.

Posologie et Administration

DOSAGE AND ADMINISTRATION PHOSPHA 250 TM NEUTRAL tablets should be taken with a full glass of water, with meals and at bedtime. Adults: One or two tablets, four times daily; Pediatric patients over 4 years of age: One tablet four times daily. Pediatric Patients under 4 years of age: Use only as directed by physician.

Side Effects Overview

ADVERSE REACTIONS: Gastrointestinal upset (diarrhea, nausea, stomach pain, and vomiting) may occur with phosphate therapy. Also, bone and joint pain (possible phosphate-induced osteomalacia) could occur. The following adverse effects may be observed (primarily from sodium or potassium): headaches; dizziness; mental confusion; seizures; weakness or heaviness of legs; unusual tiredness or weakness; muscle cramps; numbness, tingling, pain or weakness of hands or feet; numbness or tingling around lips; fast or irregular heartbeat; shortness of breath or troubled breathing; swelling of feet or lower legs; unusual weight gain; low urine output; unusual thirst. To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharma Holdings, Inc., at 1-844-874-7464 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Contre-indications

CONTRAINDICATIONS This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Frequently Asked Questions

INDICATIONS AND USAGE PHOSPHA 250 TM NEUTRAL increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age.

DOSAGE AND ADMINISTRATION PHOSPHA 250 TM NEUTRAL tablets should be taken with a full glass of water, with meals and at bedtime. Adults: One or two tablets, four times daily; Pediatric patients over 4 years of age: One tablet four times daily. Pediatric Patients under 4 years of age: Use only as directed by physician.

CONTRAINDICATIONS This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

Similar Tablet Products

Cetylpyridinium Chloride

Rheum, Crataegus, Uva-Ursi, Rhus …

Natrum Aceticum

Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride

Dextroamphetamine Saccharate, Amphetamine Aspartate, …

Valsartan

Browse all Tablet products →

References & Data Sources

• DailyMed — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate drug label (National Library of Medicine)
• openFDA — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate label data (U.S. Food & Drug Administration)
• RxNorm — RXCUI 200251 (NLM Normalized Drug Names)
• NDC Directory — Dibasic Sodium Phosphate, Monobasic Potassium Phosphate And Monobasic Sodium Phosphate (FDA National Drug Code)

Avertissement Médical

Les informations sur cette page sont destinées à des fins éducatives uniquement et ne doivent pas être utilisées en remplacement d'un avis médical professionnel, d'un diagnostic ou d'un traitement.

Consultez toujours votre médecin ou tout autre professionnel de santé qualifié pour toute question relative à une condition médicale ou à un médicament.

Sources des données : DailyMed (NLM), openFDA, MFDS